Skip to main content
    Your first consultation is complimentary.
    Board-certified physicians
    US-compounded via 503A partners
    HIPAA-compliant
    Discreet 3–5 day shipping
    Lab-monitored every 90 days

    The Journal

    Peptide science,
    plainly written.

    Evidence reviews, protocol explainers, and physician notes on the molecules we compound. Reviewed by our medical and pharmacy directors before publication.

    Showing 10 articles across all categories.

    Reading your bloodwork without panic.
    Protocols

    Reading your bloodwork without panic.

    Reference ranges are population averages — not your personal optimum. A primer on biomarker interpretation.

    Nexphoria Medical Team12 MIN
    Side effects, contraindications, and when to stop.
    Safety

    Side effects, contraindications, and when to stop.

    Every peptide has a side-effect profile. We catalog them, severity-rated, with clinical recourse.

    Nexphoria Medical Team9 MIN
    The legal landscape of compounded peptides in 2026.
    Research

    The legal landscape of compounded peptides in 2026.

    503A pharmacies, FDA enforcement discretion, and what 'research-only' really means.

    Nexphoria Medical Team14 MIN
    Subcutaneous injection — a clean, anxiety-free technique.
    Protocols

    Subcutaneous injection — a clean, anxiety-free technique.

    Done well, a sub-q injection is faster, cleaner, and less painful than a flu shot. Here is the protocol.

    Nexphoria Clinical Editorial6 MIN
    Growth hormone secretagogues: a complete clinical guide.
    Performance

    Growth hormone secretagogues: a complete clinical guide.

    CJC-1295, ipamorelin, sermorelin — what each does, how they stack, and what your IGF-1 should tell you at 90 days.

    Nexphoria Medical Team11 MIN
    NAD+, MOTS-c, and the mitochondrial theory of aging.
    Longevity

    NAD+, MOTS-c, and the mitochondrial theory of aging.

    Why cellular energy decline is measurable, what restores it, and what the clinical evidence actually supports.

    Nexphoria Medical Team10 MIN
    BPC-157 and tissue repair: what the evidence actually supports.
    Research

    BPC-157 and tissue repair: what the evidence actually supports.

    Exceptional preclinical data, limited human trials. A clear-eyed review of where BPC-157 stands in 2026.

    Nexphoria Medical Team9 MIN
    Semaglutide vs tirzepatide: one receptor or two.
    Metabolic

    Semaglutide vs tirzepatide: one receptor or two.

    Both quiet appetite. The difference is mechanism — a single incretin pathway versus two — and it shows up in the trial data and the side-effect curve.

    Nexphoria Medical Team10 MIN
    Oral vs injectable peptides: why the needle usually wins.
    Protocols

    Oral vs injectable peptides: why the needle usually wins.

    Most peptides are injected for one reason — the gut destroys them. Where oral and other routes genuinely work, and where they are marketing.

    Nexphoria Medical Team7 MIN